Blueprint Medicines (NASDAQ:BPMC) Hits New 52-Week High at $107.56

Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $107.56 and last traded at $107.00, with a volume of 391291 shares. The stock had previously closed at $94.86. Wall Street Analyst Weigh In A number of brokerages […]

Related Keywords

United States ,China ,Kate Haviland ,Stifel Nicolaus ,Christopherk Murray ,Blueprint Medicines Co ,Barclays ,Principal Financial Group Inc ,Raymond James Financial Services Advisors Inc ,Blueprint Medicines Corporation ,Needham Company ,Nasdaq ,Allspring Global Investments Holdings ,Peregrine Capital Management ,China Universal Asset Management Co ,Blueprint Medicines ,Get Free Report ,Global Investments Holdings ,Financial Group ,Universal Asset Management ,Capital Management ,Raymond James Financial Services Advisors ,James Financial Services Advisors ,Medicines Corporation ,Blueprint Medicines Daily ,Nasdaq Bpmc ,Bpmc ,Medical ,Stocks ,Technicals ,